Kidney Transplant Market Predicted to Reach $7.34 Billion by 2028, Driven by Innovations and Rising Demand for Transplants
28. Januar 2024 19:49 ET
|
Research and Markets
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Kidney Transplant Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global interest in the kidney transplant...
Sigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease Patients
14. September 2022 09:00 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Sept. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCQB: SIGY), a development-stage company focused on the creation of therapeutic solutions that address...
Rapid National Growth Drives Expansion of Healthmap Solutions Executive Leadership Team with Eric Reimer Appointed Chief Executive Officer
01. Oktober 2020 12:00 ET
|
Healthmap Solutions
TAMPA, Fla., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Healthmap Solutions (Healthmap), a growing specialty Population Health Management (PHM) company with an industry-leading Kidney Health Management (KHM)...
Regence and Healthmap Solutions partner to provide Kidney Health Management program to members
11. Juni 2020 09:00 ET
|
Healthmap Solutions
PORTLAND, Ore., June 11, 2020 (GLOBE NEWSWIRE) -- Regence today announced a new partnership with Healthmap Solutions—a growing national Population Health Management company with a flagship Kidney...
American Kidney Fund’s Kidney Kitchen™ Wins 2019 Gold MarCom Award
05. Dezember 2019 09:30 ET
|
American Kidney Fund
ROCKVILLE, Md., Dec. 05, 2019 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF)’s online Kidney Kitchen™ has won a Gold 2019 MarCom Award in the Digital Media – Website – Nonprofit category. ...
Proteon Therapeutics Announces Third Quarter 2019 Financial Results
31. Oktober 2019 17:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (“Proteon” or the “Company”) (Nasdaq: PRTO), a company that has historically focused on the development of novel,...
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
23. September 2019 16:20 ET
|
Proteon Therapeutics, Inc.
Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a Syndicate of Healthcare...
Proteon Therapeutics Announces Second Quarter 2019 Financial Results
07. August 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company that has historically focused on the development of novel, first-in-class pharmaceuticals to...
Proteon Therapeutics Announces First Quarter 2019 Financial Results
08. Mai 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 08, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics Announces Review of Potential Strategic Transactions
15. April 2019 16:30 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...